PEGVORHYALURONIDASE ALFA: 32 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
32
Total FAERS Reports
12 (37.5%)
Deaths Reported
27
Hospitalizations
32
As Primary/Secondary Suspect
2
Life-Threatening
First Report: 20150729 · Latest Report: 20191017
What Are the Most Common PEGVORHYALURONIDASE ALFA Side Effects?
#1 Most Reported
Fatigue
11 reports (34.4%)
#2 Most Reported
Diarrhoea
11 reports (34.4%)
#3 Most Reported
Ascites
9 reports (28.1%)
All PEGVORHYALURONIDASE ALFA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 11 | 34.4% | 6 | 11 |
| Fatigue | 11 | 34.4% | 8 | 10 |
| Ascites | 9 | 28.1% | 7 | 9 |
| Agitation | 8 | 25.0% | 7 | 8 |
| Aspartate aminotransferase increased | 8 | 25.0% | 6 | 8 |
| Blood alkaline phosphatase increased | 8 | 25.0% | 6 | 8 |
| Dyspnoea | 8 | 25.0% | 7 | 8 |
| Nausea | 8 | 25.0% | 6 | 7 |
| Pyrexia | 8 | 25.0% | 6 | 8 |
| Vomiting | 8 | 25.0% | 7 | 8 |
| Abdominal pain upper | 7 | 21.9% | 7 | 7 |
| Alanine aminotransferase increased | 7 | 21.9% | 6 | 7 |
| Asthenia | 7 | 21.9% | 7 | 7 |
| Back pain | 7 | 21.9% | 7 | 7 |
| Balance disorder | 7 | 21.9% | 7 | 7 |
| Blood bilirubin increased | 7 | 21.9% | 6 | 7 |
| Blood creatinine increased | 7 | 21.9% | 6 | 7 |
| Blood glucose increased | 7 | 21.9% | 6 | 7 |
| Blood phosphorus increased | 7 | 21.9% | 6 | 7 |
| Blood urea increased | 7 | 21.9% | 6 | 7 |
Who Reports PEGVORHYALURONIDASE ALFA Side Effects? Age & Gender Data
Gender: 68.2% female, 31.8% male. Average age: 66.4 years. Most reports from: US. View detailed demographics →
Is PEGVORHYALURONIDASE ALFA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 9 | 7 | 9 |
| 2016 | 1 | 1 | 1 |
| 2018 | 10 | 2 | 9 |
| 2019 | 10 | 2 | 8 |
What Is PEGVORHYALURONIDASE ALFA Used For?
| Indication | Reports |
|---|---|
| Cholangiocarcinoma | 7 |
| Her2 positive breast cancer | 7 |
| Pancreatic carcinoma metastatic | 7 |
Official FDA Label for PEGVORHYALURONIDASE ALFA
Official prescribing information from the FDA-approved drug label.